Valuation: Biogen Inc.

Market Cap 31B 26.81B 25.21B 22.91B 43.01B 2,958B 43.78B 295B 115B 1,484B 116B 114B 4,939B P/E 2026 *
37.3x
P/E 2027 * 18.4x
Enterprise Value 35.94B 31.08B 29.22B 26.56B 49.86B 3,429B 50.76B 342B 134B 1,720B 135B 132B 5,725B EV / Sales 2026 *
3.45x
EV / Sales 2027 * 3.14x
Free-Float
85.97%
Yield 2026 *
-
Yield 2027 * -
1 day-0.39%
1 week+1.72%
Current month+3.39%
1 month+0.38%
3 months+2.59%
6 months+6.77%
Current year+19.23%
1 week 201
Extreme 201
215.6
1 month 186.02
Extreme 186.025
218.59
Current year 160.36
Extreme 160.3645
219.72
1 year 131.52
Extreme 131.52
219.72
3 years 110.04
Extreme 110.035
272.23
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
13/2/26 Free

Head of Human Resources

8,025 0.0055%
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%+1.72%+55.21%-23.33% 31.12B
-0.31%+4.06%+43.08%-0.43% 80.48B
-1.02%+2.25%-3.19%+25.69% 51.06B
-3.10%-5.64%+11.56%+158.84% 48.19B
-0.74%+3.13%-49.36%-48.70% 46.5B
-0.52%+17.56%+135.48%-37.61% 25.41B
-0.30%+1.50%+39.97%+82.25% 24.43B
-1.42%+3.13%-1.26%+182.96% 21.11B
-1.83%-1.21%+59.91%+107.34% 16.28B
-1.66%-3.55%+58.52%+157.03% 15.88B
Average -1.14%+2.98%+34.99%+60.41% 36.05B
Weighted average by Cap. -1.06%+2.74%+26.58%+41.89%

Financials

2026 *2027 *
Net sales 10.43B 9.02B 8.48B 7.71B 14.47B 995B 14.73B 99.27B 38.83B 499B 39.17B 38.31B 1,662B 10.64B 9.2B 8.65B 7.86B 14.75B 1,015B 15.02B 101B 39.59B 509B 39.93B 39.06B 1,694B
Net income 953M 824M 775M 704M 1.32B 90.94B 1.35B 9.07B 3.55B 45.61B 3.58B 3.5B 152B 1.9B 1.64B 1.54B 1.4B 2.63B 181B 2.68B 18.07B 7.07B 90.9B 7.13B 6.98B 303B
Net Debt 4.94B 4.27B 4.01B 3.65B 6.85B 471B 6.97B 46.98B 18.38B 236B 18.53B 18.13B 786B 2.42B 2.09B 1.97B 1.79B 3.36B 231B 3.42B 23.03B 9.01B 116B 9.09B 8.89B 386B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
14/08/26 US$209.83 -0.39% 554,415
13/08/26 US$210.65 +0.85% 860,094
12/08/26 US$208.87 +2.44% 789,441
11/08/26 US$203.89 -1.56% 936,834
10/08/26 US$207.13 -0.39% 706,425
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
210.65USD
Average target price
237.59USD
Spread / Average Target
+12.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock